Purple Biotech stock retains Buy rating from H.C. Wainwright - Investing.com
KTOV Stock | ILA 11.00 1.90 14.73% |
About 62% of Purple Biotech's investor base is looking to short. The analysis of current outlook of investing in Purple Biotech suggests that many traders are alarmed regarding Purple Biotech's prospects. The current market sentiment, together with Purple Biotech's historical and current headlines, can help investors time the market. In addition, many technical investors use Purple Biotech stock news signals to limit their universe of possible portfolio assets.
Purple |
Purple Biotech stock retains Buy rating from H.C. Wainwright Investing.com
Read at news.google.com
Purple Biotech Fundamental Analysis
We analyze Purple Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Purple Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Purple Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Income
Net Income Comparative Analysis
Purple Biotech is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Purple Biotech Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Purple Biotech stock to make a market-neutral strategy. Peer analysis of Purple Biotech could also be used in its relative valuation, which is a method of valuing Purple Biotech by comparing valuation metrics with similar companies.
Peers
Purple Biotech Related Equities
MTDS | Meitav Dash | 1.78 | ||||
ARAD | Arad Investment | 1.49 | ||||
HRON | Hiron Trade | 1.05 | ||||
MRG | Multi Retail | 0.48 | ||||
TUZA | Teuza A | 0.53 | ||||
STEC | Sure Tech | 2.65 |
Complementary Tools for Purple Stock analysis
When running Purple Biotech's price analysis, check to measure Purple Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Purple Biotech is operating at the current time. Most of Purple Biotech's value examination focuses on studying past and present price action to predict the probability of Purple Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Purple Biotech's price. Additionally, you may evaluate how the addition of Purple Biotech to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Stocks Directory Find actively traded stocks across global markets | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |